Tag: Vasculitis

Favourable benefit-risk profile of upadacitinib in giant cell arteritis

Presented By
Prof. Peter Merkel, University of Pennsylvania, PA, USA
Trial
Phase 3, SELECT-GCA
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:22

Mycophenolate mofetil plus methotrexate is effective in Takayasu’s arteritis

Presented By
Dr Xiaochuan Sun, Peking Union Medical College Hospital, China
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:20

Is JAK inhibition the right choice for patients with relapsing giant cell arteritis?

Presented By
Dr Fernando López Gutiérrez, University Hospital Ramón y Cajal, Spain
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:33

Giant cell arteritis: Upadacitinib may be an upcoming treatment option

Presented By
Prof. Daniel Blockmans, University Hospitals Leuven, Belgium
Trial
Phase 3, SELECT-GCA
Conference
EULAR 2024
Type
Peer-reviewed article

29 July 2024 14:33

Claudin-1 is a potential antibody target for crescent glomerulonephritis

Presented By
Dr Jean-Daniel Delbet, Paris Centre de Recherche Cardiovasculaire, Paris, France
Trial
Phase 2, RENAL-F02
Conference
ERA 2024
Type
News article

20 June 2024 19:32

The REACT score predicts relapse in ANCA-associated vasculitis

Presented By
Dr Gianmarco Lugli, Meyer Children's Hospital IRCCS, Florence, Italy
Conference
ERA 2024
Type
News article

20 June 2024 19:22

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By
Prof. Ulrich Specks, Mayo Clinic, MN, USA
Trial
Phase 3, ADVOCATE
Conference
ATS 2022
Type
Peer-reviewed article

18 July 2022 11:56

ATS 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ATS 2022

9 June 2022 07:34

Vaccinated rheumatic patients carry increased risk for COVID-19 breakthrough infections

Presented By
Prof. Jasvinder Singh, University of Alabama at Birmingham, AL, USA
Conference
ACR 2021
Type
Peer-reviewed article

14 January 2022 10:47

HS patients carry higher risk for systemic lupus erythematosus

Trial
phase 1
Conference
AAD 2020
Type
Peer-reviewed article

6 August 2020 13:04

Prolonged remission after stop of tocilizumab for patients with giant cell arteritis

Presented By
Prof. John H. Stone, Harvard Medical School, Boston, USA
Trial
Phase 3, GiACTA
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 10:19

Support for tocilizumab use in giant cell arteritis

Presented By
Dr John Stone, Massachusetts General Hospital, Boston, USA
Trial
GiACTA
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 10:53
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com